Low-dose rifaximin plus N-acetylcysteine superior to rifaximin alone in IBS-diarrhea
SAN DIEGO — Rifaximin plus N-acetylcysteine outperformed rifaximin alone among patients with diarrhea-predominant irritable bowel syndrome, improving bloating, diarrhea and pain, according to research presented at Digestive Disease Week.“These patients struggle with chronic symptoms that make life challenging,” Mark Pimentel, MD, executive director of the Medically Associated